Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Estudio de cohorte PREDETERMINADO

10 de noviembre de 2026 actualizado por: Christine M. Albert, MD, MPH, Brigham and Women's Hospital

PRE-DETERMINE: Marcadores biológicos y estudio de cohorte MRI SCD

This is a prospective, multi-center cohort study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). The primary objective of this study is to determine whether biologic markers and ECGs can be utilized to advance SCD risk prediction in patients with CHD and LVEF>30-35%. The overarching goal of the study is to identify a series of markers that alone or in combination specifically predict risk of arrhythmic death as compared to other causes of mortality among this at risk population of coronary heart disease (CHD) patients with preserved left ventricular ejection fraction (LVEF> 30-35%). If biologic or ECG markers are identified that can specifically predict risk of ventricular arrhythmias, then these markers may serve as relatively inexpensive methods to identify those at risk. The public health impact of identifying markers could be quite substantial, leading to more efficient utilization of ICDs and advances in our understanding of mechanisms underlying SCD.

Descripción general del estudio

Descripción detallada

The PRE-DETERMINE Study is a prospective, multi-center study of patients with a history of coronary artery disease (CAD) and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%). Patients were enrolled at 135 sites where information on baseline demographics, clinical characteristics, pertinent past medical history, lifestyle habits, cardiac test results, and medications were collected via electronic data capture. Electrocardiograms along with a blood sample was also collected at baseline, sent to central laboratories, and stored for future analyses. Contrast-enhanced magnetic resonance imaging (CE-MRI) scans were collected on a subset of patients and analyzed. Enrollment closed in November 2013 and patients are now being followed centrally by the Clinical Coordinating Center via mail/phone to document interim non-fatal arrhythmic events and cause-specific mortality. Questionnaires that inquire about intervening ICD implantations, ICD therapies, cardiac arrest, and other pertinent cardiovascular endpoints are mailed to participants every six months, and follow-up telephone calls are made to non-responders. Study endpoints are being confirmed through review of medical records, interviews with next-of-kin, and autopsy reports, if available.

Tipo de estudio

De observación

Inscripción (Actual)

5764

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Alberta
      • Edmonton, Alberta, Canadá, T6G 2B7
        • University of Alberta
    • British Columbia
      • Vancouver, British Columbia, Canadá, V5Z 1M9
        • Vancouver General Hospital
    • Ontario
      • Mississauga, Ontario, Canadá, L5B 2P7
        • Mississauga Clinical Research Centre
    • Alaska
      • Anchorage, Alaska, Estados Unidos, 99508
        • Alaska Heart Institute
    • Arizona
      • Glendale, Arizona, Estados Unidos, 85306
        • Phoenix Heart, PLLC
      • Phoenix, Arizona, Estados Unidos, 85032
        • Cardiovascular Consultants
    • California
      • Banning, California, Estados Unidos, 92220
        • Beaver Medical Group/Clinical Care Research
    • Colorado
      • Colorado Springs, Colorado, Estados Unidos, 80909
        • Memorial Health System
      • Denver, Colorado, Estados Unidos, 80204
        • Colorado Heart and Vascular
    • Florida
      • Brandon, Florida, Estados Unidos, 33511
        • Bay Area Cardiology Associates, P.A.
      • Gainesville, Florida, Estados Unidos, 32610
        • University of Florida - Gainsville
      • Miami, Florida, Estados Unidos, 33135
        • Reliable Clinical Research
      • Miami Beach, Florida, Estados Unidos, 33140
        • Mount Sinai Medical Center
      • Orlando, Florida, Estados Unidos, 32804
        • Florida Hospital
      • Orlando, Florida, Estados Unidos, 32806
        • Orlando Regional Medical Center
      • Palm Beach Gardens, Florida, Estados Unidos, 33410
        • Palm Beach Gardens Research Center
      • Sarasota, Florida, Estados Unidos, 34233
        • Velella Research
      • Tallahassee, Florida, Estados Unidos, 32308
        • Tallahassee Research Institute, Inc.
      • West Palm Beach, Florida, Estados Unidos, 33401
        • Cardiology Associates of Palm Beach - West Palm Beach
    • Georgia
      • Covington, Georgia, Estados Unidos, 30014
        • Georgia Heart Specialist
      • Gainesville, Georgia, Estados Unidos, 30501
        • Northeast Georgia Heart Center, P.C.
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60637
        • University of Chicago
      • Chicago, Illinois, Estados Unidos, 60643
        • Advocate Medical Group
      • Chicago, Illinois, Estados Unidos, 60657
        • Advocate Medical Group - Heart and Vascular of IL
      • Melrose Park, Illinois, Estados Unidos, 60160
        • Consultants in Cardiovascular Medicine
    • Indiana
      • Anderson, Indiana, Estados Unidos, 46011
        • Community Heart and Vascular
    • Iowa
      • West Des Moines, Iowa, Estados Unidos, 50266
        • Iowa Heart Center
    • Kansas
      • Kansas City, Kansas, Estados Unidos, 66160
        • The University of Kansas
    • Kentucky
      • Lexington, Kentucky, Estados Unidos, 40503
        • Baptist Health Lexington
    • Louisiana
      • Houma, Louisiana, Estados Unidos, 70363
        • Leonard J. Chabert Medical Center
    • Maine
      • Auburn, Maine, Estados Unidos, 04210
        • Maine Research Associates
      • Lewiston, Maine, Estados Unidos, 04240
        • Maine Research Associates - Lewiston
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21201
        • University of Maryland Medical Center
    • Massachusetts
      • Ayer, Massachusetts, Estados Unidos, 01432
        • Primary Care Cardiology Research
      • Boston, Massachusetts, Estados Unidos, 02115
        • Brigham and Women's Hospital
      • Fall River, Massachusetts, Estados Unidos, 02720
        • NECCR Internal Medicine and Cardiology Associates, LLC
      • North Dartmouth, Massachusetts, Estados Unidos, 02747
        • Hawthorn Medical Associates
      • Springfield, Massachusetts, Estados Unidos, 01199
        • Baystate Cardiology
    • Michigan
      • Ann Arbor, Michigan, Estados Unidos, 48109
        • University of Michigan Medical Center
      • Dearborn, Michigan, Estados Unidos, 48124
        • Oakwood Hospital & Medical Center
      • Mount Clemens, Michigan, Estados Unidos, 48043
        • McLaren Medical Center - Macomb
      • Ypsilanti, Michigan, Estados Unidos, 48197
        • Michigan Heart
    • Minnesota
      • Minneapolis, Minnesota, Estados Unidos, 55417
        • Minneapolis VA Medical Center
    • Missouri
      • Columbia, Missouri, Estados Unidos, 65201
        • University of Missouri Health Care
    • Montana
      • Kalispell, Montana, Estados Unidos, 59901
        • Glacier View Cardiology
    • Nebraska
      • Omaha, Nebraska, Estados Unidos, 68131
        • The Cardiac Center of Creighton University
    • New Jersey
      • Bridgewater, New Jersey, Estados Unidos, 08807
        • Advanced Heartcare, LLC
      • Paterson, New Jersey, Estados Unidos, 07503
        • St. Joseph Regional Medical Center
    • New Mexico
      • Albuquerque, New Mexico, Estados Unidos, 87108
        • New Mexico VA Healthcare Systems
    • New York
      • Albany, New York, Estados Unidos, 12205
        • Albany Associates Cardiology
      • Brooklyn, New York, Estados Unidos, 11219
        • Maimonides Medical Center
      • Buffalo, New York, Estados Unidos, 14203
        • Buffalo General Hospital/Kaleida Health
      • Jamaica, New York, Estados Unidos, 11418
        • Jamaica Hospital Medical Center
      • Kingston, New York, Estados Unidos, 12401
        • Mid-Valley Cardiology
      • Mineola, New York, Estados Unidos, 11501
        • Winthrop-University Hospital
      • New York, New York, Estados Unidos, 10001
        • Gotham Cardiovascular
      • New York, New York, Estados Unidos, 10032
        • Columbia University Health Center
      • Stony Brook, New York, Estados Unidos, 11794
        • Stony Brook University Medical Center
      • Utica, New York, Estados Unidos, 13501
        • St. Elizabeth Medical Center - Hotvedt
    • North Carolina
      • Asheville, North Carolina, Estados Unidos, 28801
        • Asheville Cardiology Associates
      • Elizabeth City, North Carolina, Estados Unidos, 27909
        • Eastern Carolina Cardiovascular
      • Lenoir, North Carolina, Estados Unidos, 28645
        • Northstate Clinical Research
      • Pinehurst, North Carolina, Estados Unidos, 28374
        • Pinehurst Medical Clinic, Inc.
      • Sanford, North Carolina, Estados Unidos, 27330
        • Sanford Cardiology
      • Winston-Salem, North Carolina, Estados Unidos, 27157
        • Wake Forest
    • Ohio
      • Akron, Ohio, Estados Unidos, 44304
        • Northeast Ohio Cardiovascular Specialists
      • Cincinnati, Ohio, Estados Unidos, 45267
        • University of Cincinnati
      • Cleveland, Ohio, Estados Unidos, 44109
        • MetroHealth Medical Center
      • Elyria, Ohio, Estados Unidos, 44035
        • North Ohio Research, Ltd.
      • Fairfield, Ohio, Estados Unidos, 45014
        • Mercy Medical Associates
      • Toledo, Ohio, Estados Unidos, 43615
        • Northwest Ohio Cardiology Consultants/The Toledo Hospital
    • Oklahoma
      • Oklahoma City, Oklahoma, Estados Unidos, 73120
        • Oklahoma Foundation for Cardiovascular Research
      • Oklahoma City, Oklahoma, Estados Unidos, 73104
        • Oklahoma City VA Medical Center Veterans Research and Education Foundation
    • Pennsylvania
      • Abington, Pennsylvania, Estados Unidos, 19001
        • Abington Memorial Hospital
      • Bethlehem, Pennsylvania, Estados Unidos, 18018
        • St. Luke's Bethlehem
      • Doylestown, Pennsylvania, Estados Unidos, 18901
        • Doylestown Cardiology Associates
      • Pittsburgh, Pennsylvania, Estados Unidos, 15212
        • Allegheny General Hospital
      • Pittsburgh, Pennsylvania, Estados Unidos, 15213
        • University of Pittsburgh Medical Center
    • South Carolina
      • Anderson, South Carolina, Estados Unidos, 29621
        • AnMed Health
      • Charleston, South Carolina, Estados Unidos, 29425
        • VA Medical Center - Charleston
      • Rock Hill, South Carolina, Estados Unidos, 29732
        • Carolina Cardiology Associates
    • South Dakota
      • Rapid City, South Dakota, Estados Unidos, 57701
        • Black Hills Cardiovascular Research
    • Tennessee
      • Knoxville, Tennessee, Estados Unidos, 37917
        • Cardiovasular Research of Knoxville
      • Memphis, Tennessee, Estados Unidos, 38104
        • Memphis VA Medical Center
    • Texas
      • Houston, Texas, Estados Unidos, 77030
        • St. Luke's Episcopal Hospital
      • Houston, Texas, Estados Unidos, 77074
        • Non-Invasive Cardiovascular PA
      • Waco, Texas, Estados Unidos, 76712
        • Providence Health Center
    • Utah
      • Murray, Utah, Estados Unidos, 84157
        • Intermountain Medical Center
    • Virginia
      • Virginia Beach, Virginia, Estados Unidos, 23454
        • Cardiovascular Associates Virginia Beach
      • Rio Piedras, Puerto Rico, 00924
        • Transcatheter Medical, Inc. Centro Cardiovascular de Caguas y del Caribe

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra de probabilidad

Población de estudio

Participants have been recruited throughout multicenter sites participating in the PRE-DETERMINE Cohort Study. Patients with a history of coronary artery disease and documentation of either a prior myocardial infarction (MI) or mild to moderate left ventricular dysfunction (LVEF 35-50%) have been enrolled. The clinical study staff at each site, which was either a research nurse, fellow, or physician approached eligible patients to discuss their potential participation.

Descripción

Inclusion Criteria:

  1. Evidence of Coronary Artery Disease (CAD) a or documented prior Myocardial Infarction.

  2. LVEF >35% by any current standard evaluation technique (e.g.,) echocardiogram, MUGA, angiography). 2.1. Patients who have an LVEF between 30-35% and NYHA Class I heart failure who do not have history of ventricular tachyarrhythmias,or inducible ventricular tachycardia during electrophysiological (EP) testing can be enrolled.

  3. If documented prior MI is not present, evidence of mild-moderate systolic Left Ventricular Dysfunction with an EF >35- ≤50% as measured by any current standard screening technique (e.g.,echocardiogram, MUGA, angiography) must be present.

  4. Patients aged 18 years or above

    1. CAD will be defined as evidence of one of the following two (2) criteria:

      • Significant stenosis of a major epicardial vessel (>50% proximal or 70% distal) by coronary angiography
      • Prior revascularization (percutaneous coronary intervention or coronary artery bypass surgery)
    2. MI can be documented in the following ways:

      • From the MI hospitalization: Detection of a rise and fall of cardiac biomarkers > 99th percentile of lab (e.g., CPK elevation or Troponin at least > two times the upper limit of normal) together with myocardial ischemia with at least one of the following:

        • Symptoms of Ischemia
        • ECG changes indicative of new ischemia (new ST-T changes or new LBBB)
        • Development of pathological Q waves
        • Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
      • If no report from the MI hospitalization is available, prior MI can be met by either of the following:

        • Development of pathological Q waves
        • Imaging evidence of a region of loss of viable myocardium that is thinned and fails to contract, in the absence of a non-ischaemic cause

Exclusion Criteria:

  1. History of cardiac arrest or spontaneous or inducible sustained VT (15 beats or more at a rate of 120 BPM or greater - the occurrence of cardiac arrest or spontaneous VT in the setting of an acute MI is not considered an exclusion).
  2. Unexplained syncope
  3. Current or planned implantable cardiac defibrillator (ICD)
  4. Any condition other than cardiac disease that, in the investigator's judgment, would seriously limit life expectancy (poor survival)
  5. Metastatic cancer
  6. Marked valvular heart disease requiring surgical intervention
  7. Current or planned cardiac, renal or liver transplant
  8. Current alcohol or drug abuse
  9. Unwilling or unable to provide informed consent
  10. LVEF <35% with Class II-IV CHF or LVEF <30%
  11. Participation in a clinical trial where the active treatment arm is testing an agent and/or intervention with known antiarrhythmic properties

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: COHORT
  • Perspectivas temporales: PROSPECTIVE

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Sudden and/or arrhythmic cardiac death or resuscitated ventricular fibrillation.
Periodo de tiempo: Median follow-up estimated to be 10.7 years

A definite sudden cardiac death (SCD) is defined as a death or fatal cardiac arrest occurring within 1 hour of symptom onset or the presence of autopsy consistent with SCD (e.g. acute coronary thrombosis). Probable SCD is defined as an unwitnessed death or death during sleep where the participant was observed to be symptom-free within the preceding 24 hours. Arrhythmic death is defined as the abrupt spontaneous collapse of circulation without antecedent circulatory or neurologic impairment. Deaths classified as non-arrhythmic are not included in the primary endpoint regardless of timing. Resuscitated ventricular fibrillation is defined as out-of-hospital cardiac arrests with documented VF and/or use of external electrical defibrillation for resuscitation.

Median follow-up estimated to be 10.7 years

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Implantación de DAI
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
Seguimiento medio estimado en 10,7 años
Mortalidad cardíaca total
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
Seguimiento medio estimado en 10,7 años
Mortalidad total
Periodo de tiempo: Seguimiento medio estimado en 10,7 años
Seguimiento medio estimado en 10,7 años
ICD Shock
Periodo de tiempo: Median follow-up estimated to be 10.7 years

ICD therapies for ventricular arrhythmias over 200 BPMs will be added to the endpoint.

Median follow-up estimated to be 10.7 years
Non-Sudden or Arrhythmic Causes of Mortality
Periodo de tiempo: Median follow-up estimated to be 10.7 years

Competing causes of mortality in competing risk analyses.

Median follow-up estimated to be 10.7 years

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Christine M Albert, M.D., M.P.H., Brigham and Women's Hospital

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

1 de julio de 2007

Finalización primaria (Estimado)

1 de noviembre de 2027

Finalización del estudio (Estimado)

1 de noviembre de 2027

Fechas de registro del estudio

Enviado por primera vez

29 de abril de 2010

Primero enviado que cumplió con los criterios de control de calidad

29 de abril de 2010

Publicado por primera vez (Estimado)

3 de mayo de 2010

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

13 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir